Market revenue in 2023 | USD 24.9 million |
Market revenue in 2030 | USD 33.9 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 63.86% in 2023. Horizon Databook has segmented the Denmark pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
In May 2023, researchers from Harvard Medical School and the University of Copenhagen, in collaboration with other institutions, developed an AI tool capable of identifying individuals at high risk for pancreatic cancer up to 3 years before diagnosis.
Published in Nature Medicine, the study utilized 9 million patient records from Denmark and the U.S. to train the AI. By analyzing disease codes and their temporal sequences, the AI accurately predicted pancreatic cancer risk, even in patients without family history or genetic predisposition.
The tool aims to facilitate early detection and intervention, crucial for improving outcomes in cancer known for its late diagnosis and poor survival rates, representing a significant advancement in AI-driven healthcare applications.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark pancreatic cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into Denmark pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account